-
Sort By
-
Newest
-
Newest
-
Oldest
Vaccine trial restart boosts markets, ASX strength to continue, COVID-19 impacting Macquarie Group A positive lead from Wall Street and news that AstraZeneca plc (NYSE:AZN) had resumed their vaccine trial sent the ASX 200 (ASX:XJO) 0.7% higher on Monday. Positive news on the vaccine front support the energy and industrial sectors amid hope of a…
It was a mixed day for the market, the ASX 200 (ASX:XJO) finished 0.2% higher despite trading up as much as 0.8% during the day.
Pandemic tailwind to flow into 2021 for Woolies Woolworths Ltd (ASX:WOW) delivered a weaker than expected result, despite a 6% increase in revenue to $63.6 billion for the financial year. Net profit fell to $1.166 billion with the biggest hit coming from the mothballed Hotels division. Sales revenue improved across the board with Australian and…